Targeted mutations in beta1,4-galactosyltransferase I reveal its multiple cellular functions

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Beta1,4-galactosyltransferase I (GalT I) is a key enzyme in the trans-Golgi, essential for oligosaccharide chain elongation in glycoproteins and glycolipids.
• GalT I also exhibits non-Golgi functions, including potential roles as a cell surface receptor for extracellular glycosides.
• The GalT I gene produces two protein isoforms differing in cytoplasmic domain length, prompting investigation into their distinct biological roles.

Purpose of the Study:

• To investigate the distinct biological roles of the two GalT I protein isoforms.
• To understand the consequences of GalT I isoform deficiency on cellular functions and overall organismal viability.

Main Methods:

• Cloning of GalT I cDNAs to identify gene products.
• Generation of targeted mutations to eliminate either both GalT I isoforms or specifically the long isoform.
• Analysis of galactosylation activity and phenotypic abnormalities in mutant models.

Main Results:

• Elimination of both GalT I isoforms resulted in significant loss of GalT activity, indicating the existence of other family members, and led to neonatal lethality with diverse abnormalities attributed to reduced galactosylation.
• Loss of only the long GalT I isoform allowed for largely normal galactosylation via the short isoform but caused specific defects in cell interactions.
• These cell interaction defects are hypothesized to be linked to a non-biosynthetic function of the long GalT I isoform.

Conclusions:

• Beta1,4-galactosyltransferase I (GalT I) plays a critical role in cellular biosynthesis and potentially in cell-cell interactions.
• The two GalT I isoforms exhibit partially distinct functions, with the long isoform implicated in non-biosynthetic roles affecting cell interactions.
• Complete loss of GalT I function leads to severe developmental defects and lethality, underscoring its essentiality.